Method for increasing the yield of properly folded recombinant human gamma interferon from inclusion bodies

被引:132
作者
Arora, D [1 ]
Khanna, N [1 ]
机构
[1] INT CTR GENET ENGN & BIOTECHNOL,RECOMBINANT GENE PROD GRP,NEW DELHI 110067,INDIA
关键词
gamma-interferon; purification; refolding; downstream processing;
D O I
10.1016/S0168-1656(96)01636-7
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A strategy is described for improved refolding and purification of recombinant human gamma interferon (rh-IFN gamma), which could warrant a higher yield and specific activity than reported previously. The optimal conditions of refolding are obtained by addition of a labilizing agent, L-arginine, in the refolding buffer. A 10-fold increase in the yield was observed with 0.5 M L-arginine, compared with renaturation in its absence. By varying renaturation parameters, the conditions that allow functional refolding of similar to 25-30% of the recombinant protein have been standardized. A simple process is also described for the purification of rh-IFN gamma. The purification involves a single-column chromatography on S-Sepharose, after refolding of rh-IFN gamma in arginine containing buffer. This procedure has consistently produced rh-IFN gamma having a purity of at least 97%, the rest being the aggregated form of gamma interferon. The purified protein is a dimer under non-denaturing conditions and has a specific activity of 2 x 10(8) IU mg(-1) protein, as measured by viral cytopathic assay. (C) 1996 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 14 条
  • [1] ARAKAWA T, 1985, J BIOL CHEM, V260, P4435
  • [2] A METHOD FOR INCREASING THE YIELD OF PROPERLY FOLDED RECOMBINANT FUSION PROTEINS - SINGLE-CHAIN IMMUNOTOXINS FROM RENATURATION OF BACTERIAL INCLUSION-BODIES
    BUCHNER, J
    PASTAN, I
    BRINKMANN, U
    [J]. ANALYTICAL BIOCHEMISTRY, 1992, 205 (02) : 263 - 270
  • [3] RENATURATION, PURIFICATION AND CHARACTERIZATION OF RECOMBINANT FAB-FRAGMENTS PRODUCED IN ESCHERICHIA-COLI
    BUCHNER, J
    RUDOLPH, R
    [J]. BIO-TECHNOLOGY, 1991, 9 (02): : 157 - 162
  • [4] KUNG H, 1994, Patent No. 5278286
  • [5] STRUCTURE OF INTERFERONS
    LANGER, JA
    PESTKA, S
    [J]. PHARMACOLOGY & THERAPEUTICS, 1985, 27 (03) : 371 - 401
  • [6] LEWIS JA, 1988, CYTOKINES, P108
  • [7] MAREKOV LN, Patent No. 0446582
  • [8] NAGABHUSAN TL, 1989, Patent No. 4751078
  • [9] OLIGOMERIC STRUCTURE OF RECOMBINANT HUMAN AND MURINE IMMUNE INTERFERONS BY MEANS OF SEDIMENTATION EQUILIBRIUM
    NAGATA, K
    IZUMI, T
    KITAGAWA, T
    YOSHIDA, N
    [J]. JOURNAL OF INTERFERON RESEARCH, 1987, 7 (03): : 313 - 320
  • [10] INTERFERONS AND THEIR ACTIONS
    PESTKA, S
    LANGER, JA
    ZOON, KC
    SAMUEL, CE
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 : 727 - 777